Clinical Research Outsourcing and India

Countries covered: India A Clinical research (CR) organization is one that manages a research or an investigation to assess and/or verify the clinical, pharmacological or other pharmacodynamic effects, safety and/or efficacy and adverse reactions of an investigational product. Clinical research (CR) organizations were primarily organized as outsourcing service companies that provided only clinical trial management. However, in recent times, most of them have expanded their scope of services to provide comprehensive management of complex drug trial processes for their client companies as well as to facilitate access to vast areas of expertise, which may not exist in the client's internal organization. Over the past few years, CR organizations have garnered bulk of the outsourced clinical research revenue share. Till 1990, India was not the preferred destination for major global pharmaceutical companies, even though some of them were conducting clinical trials here. In the last 10 years however, there has been a steep rise in the global demand for world class clinical trial management capacity and productivity. With the average R&D expenditure growing at more than 15% per year, biopharmaceutical majors worldwide are realizing that the time-consuming and expensive affair of drug discovery and development can be done easier and better in India, given its rich technical resource pool, the relative ease & attractive economics of recruiting large number of patients and the sheer diversity inherent in the country’s genetic texture. The international biopharmaceutical sector now finds India’s pool of highly skilled doctors, trained medical personnel, investigators, and the support research infrastructure to be highly attractive and as a result, large numbers of international companies are now viewing India as a potential center of knowledge, skills and resources, and are hoping to derive expertise-based synergies from Indian partners. This report titled “Clinical Research Outsourcing and India” is based on extensive secondary research, well complemented by inputs from limited primary research, wherever found necessary. Apart from providing basic statistics on the domestic & global CRO market sizes, growth projections and market share details, this report provides ample qualitative coverage on the global clinical research industry, capturing all the recent key trends therein. The report outlines the top countries and companies that outsource and the selection criteria that are generally adopted by such global companies to evaluate Indian businesses before a decision is taken on outsourcing clinical research activities. The report explores emerging business models, growth drivers, and the scope for outsourced clinical research business in a country like India and, consequently, the strategies that have been adopted by the contract research organizations and their plans to grab their share of the global CRO pie.

Additional Information

Scope e-Knowledge Center’s (SCOPE’s) patented INTELLISEARCH methodology was used extensively to scour Web sources, and other paid databases and print publications were also consulted in addition, to prepare this report. The limited but comprehensive primary research study was carried out among select respondent categories including existing clinical research organizations and potential players, major drug producers, and technical experts. [SCOPE is a leading information and research organisation helping clients build intellectual property. Scope offers research and analysis services and world class database to clients in the US, the UK and continental Europe. In operation for over 19 years, Scope has built a strong international clientele. Headquartered in Chennai, India, Scope has marketing/business associates spanning New York, London, Cologne and Brussels. (Please visit www.scopeknowledge.com for details.)]

More India Research & Development Reports

Oncology Pharmaceuticals Market in India 2012 by Netscribes (India) Pvt. Ltd.
Oncology pharmaceuticals market in India, a leading segment of the overall pharmaceuticals market is the fourth largest in volume and eighth largest in value in ...

Cardiovascular Pharmaceuticals Market in India 2012 by Netscribes (India) Pvt. Ltd.
Cardiovascular pharmaceuticals market in India is the second largest contributor to domestic pharmaceutical sales, contributing around 15.6%. Since India has a huge patient pool, the ...

Clinical Trials Market in India 2012 by Netscribes (India) Pvt. Ltd.
The Indian clinical trials market is growing at an excellent rate and currently witnessing a large number of global pharmaceutical companies outsourcing trials to contract ...

Clinical Trials in India by Cygnus Business Consulting and Research
Clinical Trial industry in India touched US$400 million in 2010 and is expected to touch US$1.09 billion by 2014. Clinical Trials market in India ...

Special Report: Opportunities in Emerging Markets—Developing Asia by Decision Resources
Asia boasts 6 of the 20 largest economies in the world: China, Japan, India, Russia, Australia, and Indonesia. The countries of developing Asia are all ...

See all reports like this >>

More India Reports

D&B Country RiskLine Report: India by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: India by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Country Report India January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Spirits - BRIC (Brazil, Russia, India, China) Industry Guide by MarketLine
Datamonitor's Spirits - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, ...

Wine - BRIC (Brazil, Russia, India, China) Industry Guide by MarketLine
Datamonitor's Wine - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, ...

See all reports like this >>